scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.UROLONC.2010.03.002 |
P8608 | Fatcat ID | release_36qxb25jvbbw7eysj5adkjuabq |
P698 | PubMed publication ID | 22154358 |
P2093 | author name string | Victoria L Robinson | |
Kristen B Otto | |||
Sujeet S Acharya | |||
P2860 | cites work | Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms | Q24312029 |
Characterization of the structure and function of a novel MAP kinase kinase (MKK6) | Q24336966 | ||
Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase | Q24655723 | ||
Cancer statistics, 2008 | Q27860585 | ||
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions | Q29547189 | ||
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation | Q29614227 | ||
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer | Q33247062 | ||
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder | Q33317632 | ||
Generation of a concise gene panel for outcome prediction in urinary bladder cancer | Q33561596 | ||
Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase | Q34462888 | ||
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? | Q36341182 | ||
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells | Q38498843 | ||
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity | Q39752793 | ||
Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. | Q40048075 | ||
Differential susceptibility to TRAIL of normal versus malignant human urothelial cells. | Q40330291 | ||
Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. | Q40473062 | ||
Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength | Q40852104 | ||
Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines | Q46976418 | ||
P433 | issue | 4 | |
P304 | page(s) | 415-420 | |
P577 | publication date | 2011-12-11 | |
P1433 | published in | Urologic Oncology | Q2113446 |
P1476 | title | Stress-activated kinase pathway alteration is a frequent event in bladder cancer | |
P478 | volume | 30 |
Q47386000 | Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer. |
Q40468889 | Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population. |
Q40745717 | Inflammatory-Related Genetic Variants in Non-Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. |
Q34685436 | Multiple mechanisms mediate resistance to sorafenib in urothelial cancer |
Q60601167 | Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration |
Q36265434 | The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells |
Search more.